SOUTH SAN FRANCISCO, CA – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, announced that Fierce… Read More
PGDx elio™ plasma focus Dx is the industry’s first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw BURLINGTON, NC… Read More
Dr. Stewart J. Tepper, MD has recently published a comprehensive paper in “Practical Neurology” on the latest developments in neuromodulation devices for the treatment of migraine. The paper, co-authored with… Read More
The Company also provides an update on the Silicon Valley Bank convertible debt facility Including the new C$12 million convertible debt facility, Eupraxia anticipates it has sufficient cash to fund… Read More
Cerevel’s clinical-stage assets complement AbbVie’s emerging neuroscience pipeline and leading on-market brands in psychiatry, migraine and Parkinson’s disease Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be… Read More
